View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 27, 2011

Accuray wins FDA clearance for Dose Control System

Radiation oncology company Accuray has been granted US Food and Drug Administration (FDA) approval for the Dose Control System, a new feature for the company's TomoTherapy system.

Radiation oncology company Accuray has been granted US Food and Drug Administration (FDA) approval for the Dose Control System, a new feature for the company’s TomoTherapy system.

The TomoTherapy system enables doses to be precisely applied to target structures while sparing healthy tissue.

The Dose Control System ensures a stable output for treatments with a long duration, including total marrow and total body irradiation.

Accuray president and CEO Euan Thomson said that the Dose Control System can improve the TomoTherapy system’s performance.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management